These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 30444601)
1. Hydrogen-Bonded Tannic Acid-Based Anticancer Nanoparticle for Enhancement of Oral Chemotherapy. Le Z; Chen Y; Han H; Tian H; Zhao P; Yang C; He Z; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y ACS Appl Mater Interfaces; 2018 Dec; 10(49):42186-42197. PubMed ID: 30444601 [TBL] [Abstract][Full Text] [Related]
2. Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells. Chowdhury P; Nagesh PKB; Hatami E; Wagh S; Dan N; Tripathi MK; Khan S; Hafeez BB; Meibohm B; Chauhan SC; Jaggi M; Yallapu MM J Colloid Interface Sci; 2019 Feb; 535():133-148. PubMed ID: 30292104 [TBL] [Abstract][Full Text] [Related]
3. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration. Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456 [TBL] [Abstract][Full Text] [Related]
4. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419 [TBL] [Abstract][Full Text] [Related]
6. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells. Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697 [TBL] [Abstract][Full Text] [Related]
7. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel. Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677 [TBL] [Abstract][Full Text] [Related]
8. Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system. Hou J; Sun E; Sun C; Wang J; Yang L; Jia XB; Zhang ZH Int J Pharm; 2016 Oct; 512(1):186-193. PubMed ID: 27567930 [TBL] [Abstract][Full Text] [Related]
9. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency. Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy. Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777 [TBL] [Abstract][Full Text] [Related]
11. Polylysine and cysteine functionalized chitosan nanoparticle as an efficient platform for oral delivery of paclitaxel. Du X; Yin S; Xu L; Ma J; Yu H; Wang G; Li J Carbohydr Polym; 2020 Feb; 229():115484. PubMed ID: 31826482 [TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer. Lv W; Cheng L; Li B Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039 [TBL] [Abstract][Full Text] [Related]
13. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500 [TBL] [Abstract][Full Text] [Related]
14. Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery. Hu L; Li M; Zhang Z; Shen Y; Guo S Int J Pharm; 2018 Dec; 553(1-2):510-521. PubMed ID: 30308274 [TBL] [Abstract][Full Text] [Related]
15. Novel oral administrated paclitaxel micelles with enhanced bioavailability and antitumor efficacy for resistant breast cancer. Zhang T; Luo J; Fu Y; Li H; Ding R; Gong T; Zhang Z Colloids Surf B Biointerfaces; 2017 Feb; 150():89-97. PubMed ID: 27898360 [TBL] [Abstract][Full Text] [Related]
16. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors. Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289 [TBL] [Abstract][Full Text] [Related]
17. Biomimetic Shells Endow Sub-50 nm Nanoparticles with Ultrahigh Paclitaxel Payloads for Specific and Robust Chemotherapy. Chen X; Ling X; Zhao L; Xiong F; Hollett G; Kang Y; Barrett A; Wu J ACS Appl Mater Interfaces; 2018 Oct; 10(40):33976-33985. PubMed ID: 30203956 [TBL] [Abstract][Full Text] [Related]
18. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy. Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390 [TBL] [Abstract][Full Text] [Related]
20. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel. Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]